Metraipolis › archive › dc_82f71a425acd

Towards human cardiac new approach methodologies (NAMs) to evaluate the combination of repolarization prolonging and shortening drugs: a pilot study — Europe PMC PMID:41383657

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41383657
DOI
10.3389/fddsv.2025.1679626
License (as archived)
solo-consultazione
Archived
2026-11-08T20:56:52.488Z
SHA-256 of the archived text
663eb14c82ddf00fbc9f1a55577a27de45fa3fbb07c1c2f3c77171978614b5c0
Stable URL of this page
https://metraipolis.com/documento/dc_82f71a425acd

How to cite

Towards human cardiac new approach methodologies (NAMs) to evaluate the combination of repolarization prolonging and shortening drugs: a pilot study — Europe PMC PMID:41383657 — Europe PMC (en), https://europepmc.org/article/MED/41383657 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_82f71a425acd (Metraipolis archive dc_82f71a425acd, sha256 663eb14c82ddf00fbc9f1a55577a27de45fa3fbb07c1c2f3c77171978614b5c0)
BibTeX
@misc{dc82f71a425acd,
  title = {Towards human cardiac new approach methodologies (NAMs) to evaluate the combination of repolarization prolonging and shortening drugs: a pilot study — Europe PMC PMID:41383657},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41383657},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_82f71a425acd; sha256 663eb14c82ddf00fbc9f1a55577a27de45fa3fbb07c1c2f3c77171978614b5c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41383657. Agents can read the archived copy with the MCP tool read_document.